Table 2 : Outcome measures after 15 weeks of intervention.

Measure	Group (A) (n=20) X±SD		Group (B) (n=20) X±SD		Mean difference	p-value
	pre	post	pre	post
Body weight(Kg)	105±2.15	94.75±1.9	100±2.9	94.15± 3.1	-0.6±3.7	0.8
BMI(Kg/m2)	39.01±0.67	35.45±0.59	39.14±0.87	36.59±0.98	-1.13±1.1	0.33
WC(cm)	114.3±1.68	102.8±1.5	116.4±1.85	109.4±2.15	-6.5±2.6	0.017
LANSS	21.75±0.45	16.85±0.69	21.80±0.42	20.45±0.37	-3.6±0.7	0.0001
LEFS	55.30±1.18	66.50±1.12	56.35±1.24	65.30±1.70	1.2±2.03	0.55
OGTT:
FBG(mg/dl)	118.1±1.11	89.65±2.14	116.8±1.37	96.2±2.01	-6.5±2.9	0.03
60-minute PP(mg/dl)	182.2±8.40	120.5±4.6	206.2±5.55	163.3±4.17	-42.75±6.2	0.0001
90-minute PP(mg/dl)	175.4±8.2	115.6±3.6	188±3.75	148.5±2.5	-32.85±4.5	0.0001
120-minute PP(mg/dl)	156.6±5.47	100±1.5	166.45±2.2	120.2±1.5	-20.15±2.2	0.0001

X: mean; SD: standard deviation; MD: mean difference; BMI: body mass index;
WC: waist circumference;
LANSS: Leeds Assessment of Neuropathic symptoms and signs Scale;
LEFS: lower extremity functional scale; OGTT: oral glucose tolerance test;
FBG: fasting blood glucose; PP: post prandial